Authors reply to Letter to the Editor- In response to: Comment on Durrani et al."s "Adalimumab for Ocular Inflammation"
Durrani, Khayyam, John Kempen, Stephen Foster, and Systemic Immunosuppressive Therapy Eye Diseases (SITE) Research Group. 2017. “Authors Reply to Letter to the Editor- In Response To: Comment on Durrani et Al."s ‘Adalimumab for Ocular Inflammation’”. Ocul Immunol Inflamm, 1.